We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$535M
AUM Growth
+$28M
Cap. Flow
+$20.7M
Cap. Flow %
3.87%
Top 10 Hldgs %
17.17%
Holding
336
New
30
Increased
83
Reduced
125
Closed
34

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.63M
2
MYGN icon
Myriad Genetics
MYGN
+$5.27M
3
AMBA icon
Ambarella
AMBA
+$4.33M
4
EVER icon
EverQuote
EVER
+$3.93M
5
AGX icon
Argan
AGX
+$3.72M

Top Sells

Rank Stock Value
1
DGII icon
Digi International
DGII
+$7.01M
2
COUR icon
Coursera
COUR
+$5.05M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$4.54M
4
ICHR icon
Ichor Holdings
ICHR
+$4.04M
5
KRUS icon
Kura Sushi USA
KRUS
+$3.31M

Sector Composition

Rank Sector Weight
1 Industrials 28.91%
2 Technology 24.08%
3 Healthcare 20.66%
4 Financials 5.77%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
76
Arrowhead Research
ARWR
$12.3B
$2.66M 0.5%
102,262
+29,963
+41% +$736K
VMI icon
77
Valmont Industries
VMI
$9.52B
$2.63M 0.49%
9,594
-792
-8% -$193K
MTDR icon
78
Matador Resources
MTDR
$6.5B
$2.63M 0.49%
44,132
+6,600
+18% +$415K
BGC icon
79
BGC Group
BGC
$5.12B
$2.59M 0.48%
312,204
+77,046
+33% +$634K
EVR icon
80
Evercore
EVR
$11.5B
$2.58M 0.48%
12,373
-385
-3% -$74.9K
STXS icon
81
Stereotaxis
STXS
$139M
$2.56M 0.48%
1,406,412
+212,423
+18% +$476K
CLPT icon
82
ClearPoint Neuro
CLPT
$463M
$2.49M 0.47%
462,586
+132,707
+40% +$768K
ORN icon
83
Orion Group Holdings
ORN
$402M
$2.48M 0.46%
260,972
+4,548
+2% +$40.2K
HLIO icon
84
Helios Technologies
HLIO
$2.66B
$2.44M 0.46%
+51,080
New +$2.45M
HRTX icon
85
Heron Therapeutics
HRTX
$64.7M
$2.44M 0.46%
+695,993
New +$2.14M
BWXT icon
86
BWX Technologies
BWXT
$15.8B
$2.43M 0.45%
25,542
+24,239
+1,860% +$2.25M
PAYX icon
87
Paychex
PAYX
$42.8B
$2.41M 0.45%
20,351
-4,050
-17% -$495K
TILE icon
88
Interface
TILE
$2.23B
$2.4M 0.45%
+163,504
New +$2.54M
GDRX icon
89
GoodRx Holdings
GDRX
$1.22B
$2.38M 0.44%
+304,770
New +$2.26M
SMWB icon
90
Similarweb
SMWB
$770M
$2.37M 0.44%
304,544
+44,094
+17% +$343K
HUBB icon
91
Hubbell
HUBB
$27.1B
$2.36M 0.44%
6,458
– –
MTRX icon
92
Matrix Service
MTRX
$330M
$2.36M 0.44%
237,421
+31,860
+15% +$364K
DCBO
93
Docebo
DCBO
$561M
$2.31M 0.43%
59,769
+15,548
+35% +$638K
UVE icon
94
Universal Insurance Holdings
UVE
$1.18B
$2.3M 0.43%
+122,501
New +$2.38M
FTDR icon
95
Frontdoor
FTDR
$5.89B
$2.29M 0.43%
67,635
+33,844
+100% +$1.14M
ADPT icon
96
Adaptive Biotechnologies
ADPT
$4.02B
$2.26M 0.42%
623,825
+346,729
+125% +$1.1M
PESI icon
97
Perma-Fix Environmental Services
PESI
$412M
$2.22M 0.42%
219,130
+29,680
+16% +$329K
MDWD icon
98
MediWound
MDWD
$179M
$2.22M 0.41%
142,794
+10,307
+8% +$170K
BLDR icon
99
Builders FirstSource
BLDR
$7.79B
$2.15M 0.4%
15,567
+3,936
+34% +$668K
ITCI
100
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.15M 0.4%
31,448
+30,215
+2,451% +$2.1M
2 3
4
5 6

Similar funds

AMM
American Money Management Rancho Santa Fe, California $632M AUM 14.06% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return

Essex Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Essex Investment Management held 336 positions worth $535M, up 5.5% from $507M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management deployed $20.7M of net new capital in Q2 2024, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Aspen Aerogels, an estimated $2.12M trimmed.

  • Essex Investment Management's largest Q2 2024 buy was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.
  • Essex Investment Management added most to AvePoint in Q2 2024, an estimated $3.22M increase.
  • Essex Investment Management's biggest Q2 2024 reduction was Aspen Aerogels, cutting an estimated $2.12M.
  • Essex Investment Management fully exited Digi International in Q2 2024, selling an estimated $7.01M.
  • Essex Investment Management's ten largest holdings make up 17% of its $535M portfolio in Q2 2024.
  • Essex Investment Management opened 30 new positions and closed 34 in Q2 2024.
  • Essex Investment Management's portfolio value rose 5.5% quarter-over-quarter to $535M.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.